Diversified Research Development from 2010 to 2026
| DHCNL Stock | USD 18.10 0.06 0.33% |
Research Development | First Reported 2010-12-31 | Previous Quarter 0.17 | Current Value 0.17 | Quarterly Volatility 0.14828431 |
Check Diversified Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diversified Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 344.2 M, Selling General Administrative of 30.3 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.72, Dividend Yield of 0.0078 or PTB Ratio of 1.08. Diversified financial statements analysis is a perfect complement when working with Diversified Healthcare Valuation or Volatility modules.
Diversified | Research Development | Build AI portfolio with Diversified Stock |
Historical Research Development data for Diversified Healthcare serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Diversified Healthcare Trust represents a compelling investment opportunity.
Latest Diversified Healthcare's Research Development Growth Pattern
Below is the plot of the Research Development of Diversified Healthcare Trust over the last few years. It is Diversified Healthcare's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Diversified Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Diversified Research Development Regression Statistics
| Arithmetic Mean | 0.18 | |
| Geometric Mean | 0.14 | |
| Coefficient Of Variation | 84.31 | |
| Mean Deviation | 0.09 | |
| Median | 0.13 | |
| Standard Deviation | 0.15 | |
| Sample Variance | 0.02 | |
| Range | 0.66 | |
| R-Value | 0.04 | |
| Mean Square Error | 0.02 | |
| R-Squared | 0 | |
| Significance | 0.89 | |
| Slope | 0 | |
| Total Sum of Squares | 0.35 |
Diversified Research Development History
About Diversified Healthcare Financial Statements
Diversified Healthcare investors utilize fundamental indicators, such as Research Development, to predict how Diversified Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 0.19 | 0.17 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Diversified Healthcare Correlation against competitors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Diversified Healthcare. Projected growth potential of Diversified fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Diversified Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.68) | Revenue Per Share | Quarterly Revenue Growth 0.541 | Return On Assets | Return On Equity |
Understanding Diversified Healthcare requires distinguishing between market price and book value, where the latter reflects Diversified's accounting equity. The concept of intrinsic value - what Diversified Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Diversified Healthcare's price substantially above or below its fundamental value.
It's important to distinguish between Diversified Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Diversified Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Diversified Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.